| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-07 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |